The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
Brahm, Cyrillo G, van Linde, Myra E, Enting, Roelien H, Schuur, Maaike, Otten, René H J, Heymans, Martijn W, Verheul, Henk M W, Walenkamp, Annemiek M E
Published in Cancers (04.03.2020)
Published in Cancers (04.03.2020)
Get full text
Journal Article
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
van Linde, Myra E., Brahm, Cyrillo G., de Witt Hamer, Philip C., Reijneveld, Jaap C., Bruynzeel, Anna M. E., Vandertop, W. Peter, van de Ven, Peter M., Wagemakers, Michiel, van der Weide, Hiske L., Enting, Roelien H., Walenkamp, Annemiek M. E., Verheul, Henk M. W.
Published in Journal of neuro-oncology (01.10.2017)
Published in Journal of neuro-oncology (01.10.2017)
Get full text
Journal Article
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
van Linde, Myra E, Labots, Mariette, Brahm, Cyrillo G, Hovinga, Koos E, De Witt Hamer, Philip C, Honeywell, Richard J, de Goeij-de Haas, Richard, Henneman, Alex A, Knol, Jaco C, Peters, Godefridus J, Dekker, Henk, Piersma, Sander R, Pham, Thang V, Vandertop, William P, Jiménez, Connie R, Verheul, Henk M W
Published in Clinical cancer research (14.04.2022)
Published in Clinical cancer research (14.04.2022)
Get full text
Journal Article
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study
Brahm, Cyrillo G., den Hollander, Martha W., Enting, Roelien H., de Groot, Jan Cees, Solouki, A. Millad, den Dunnen, Wilfred F. A., Heesters, Mart A. A. M., Wagemakers, Michiel, Verheul, Henk M. W., de Vries, Elisabeth G. E., Pruim, Jan, Walenkamp, Annemiek M. E.
Published in European journal of nuclear medicine and molecular imaging (01.12.2018)
Published in European journal of nuclear medicine and molecular imaging (01.12.2018)
Get full text
Journal Article
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Janssen, Jorien B E, Brahm, Cyrillo G, Driessen, Chantal M L, Nuver, Janine, Labots, Mariette, Kouwenhoven, Mathilde C M, Sanchez Aliaga, Esther, Enting, Roelien H, de Groot, Jan Cees, Walenkamp, Annemiek M E, van Linde, Myra E, Verheul, Henk M W
Published in Brain communications (2024)
Published in Brain communications (2024)
Get full text
Journal Article
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
Brahm, Cyrillo G, Abdul, U Kulsoom, Houweling, Megan, van Linde, Myra E, Lagerweij, Tonny, Verheul, Henk M W, Westerman, Bart A, Walenkamp, Annemiek M E, Fehrmann, Rudolf S N
Published in Neuro-oncology advances (01.01.2020)
Published in Neuro-oncology advances (01.01.2020)
Get full text
Journal Article
Abstract CT117: A Phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study
Brahm, Cyrillo G., Linde, Myra E. van, Labots, Mariette, Kouwenhoven, Mathilde C., Aliaga, Esther Sanchez, Enting, Roelien H., Appelman, Auke P., Nuver, Janine, Walenkamp, Annemiek M., Verheul, Henk M.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Tumor drug concentration and phosphoproteomic profiles after two weeks of treatment with sunitinib in patients with newly-diagnosed glioblastoma
van Linde, Myra E, Labots, Mariette, Brahm, Cyrillo G, Hovinga, Koos E, De Witt Hamer, Philip C, Honeywell, Richard J, de Goeij-de Haas, Richard, Henneman, Alex A, Knol, Jaco C, Peters, Godefridus J, Dekker, Henk, Piersma, Sander R, Pham, Thang V, Vandertop, William P, Jiménez, Connie R, Verheul, Henk M W
Published in Clinical cancer research (14.02.2022)
Get full text
Published in Clinical cancer research (14.02.2022)
Journal Article